Sonova Holding (OTCMKTS:SONVY) Sees Large Increase in Short Interest

Sonova Holding (OTCMKTS:SONVY) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 1,508 shares, a growth of 75.8% from the June 30th total of 858 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 36,640 shares, the days-to-cover ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on SONVY. Citigroup reissued a “sell” rating on shares of Sonova in a report on Friday, July 24th. Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, June 23rd. Finally, UBS Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.

Sonova Stock Performance

Shares of OTCMKTS:SONVY traded down $0.17 during trading on Thursday, hitting $54.30. 4,050 shares of the company were exchanged, compared to its average volume of 34,342. The stock has a 50 day moving average of $50.70 and a 200 day moving average of $49.72. Sonova has a 52-week low of $42.26 and a 52-week high of $61.09. The company has a current ratio of 1.75, a quick ratio of 1.43 and a debt-to-equity ratio of 0.51.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.